C
Christina D. Smolke
Researcher at Stanford University
Publications - 140
Citations - 9792
Christina D. Smolke is an academic researcher from Stanford University. The author has contributed to research in topics: Synthetic biology & RNA. The author has an hindex of 46, co-authored 132 publications receiving 8478 citations. Previous affiliations of Christina D. Smolke include University of California, Berkeley & California Institute of Technology.
Papers
More filters
Journal ArticleDOI
Complete biosynthesis of opioids in yeast
Stephanie Galanie,Kate Thodey,Isis Trenchard,Maria V. Filsinger Interrante,Christina D. Smolke +4 more
TL;DR: Yeast is engineered to produce the opioid compounds thebaine and hydrocodone, starting from sugar, a proof of principle, and major hurdles remain before optimization and scale-up could be achieved.
Journal ArticleDOI
Higher-Order Cellular Information Processing with Synthetic RNA Devices
TL;DR: This work developed a general approach for assembling RNA devices that can execute higher-order cellular information processing operations from standard components that can function as logic gates and signal filters, and exhibit cooperativity.
Journal ArticleDOI
Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes
Brian F. Pfleger,Douglas J. Pitera,Christina D. Smolke,Christina D. Smolke,Jay D. Keasling,Jay D. Keasling +5 more
TL;DR: A method for tuning the expression of multiple genes within operons by generating libraries of tunable intergenic regions (TIGRs), recombining various post-transcriptional control elements and screening for the desired relative expression levels is described.
Journal ArticleDOI
Programmable ligand-controlled riboregulators of eukaryotic gene expression.
TL;DR: The design of a class of small trans-acting RNAs that directly regulate gene expression in a ligand-dependent manner, called antiswitches, are described, made fully tunable and modular by rational design.
Journal ArticleDOI
A modular and extensible RNA-based gene-regulatory platform for engineering cellular function
TL;DR: An extensible RNA-based framework for engineering ligand-controlled gene-regulatory systems, called ribozyme switches, that exhibits tunable regulation, design modularity, and target specificity is reported.